Live news related to THERACLION stock (FR0010120402): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on THERACLION mainly cover earnings publications, analyst notes et the dividend and payout policy. The stock trades at €0,70 on Euronext Paris, down 5,41% at the last update. This page lists the articles published on THERACLION stock to track the share price, company announcements and any item likely to influence market perception.
The upside potential of 189% retained by the research firm, calculated on the closing price of October 26, 2026, is based on an already established ma…
Theraclion is approaching a major regulatory milestone: the FDA decision on the De Novo application for Sonovein is expected between the end of the th…
On July 8, 2026, Theraclion appointed Vincent Gardès as the chairman of its board of directors, replacing Claude Lenoir who has been the interim chair…
Theraclion announced on Thursday the departure of Yann Duchesne from the chairmanship of the board of directors, a position he had held since January …
Theraclion announced on Monday the approval by the American Medical Association of a new billing code (Category III CPT) for non-invasive treatment of…
Theraclion presented the preliminary results of its Sonovein SpeedPulse prototype at the international congress of the Phlebology Days in Parma, held …
The stock of the French medtech company specializing in therapeutic ultrasound is trading at 0.549€ this Tuesday, April 28, 2026, marking a 14.38% inc…
